Back to search
Platinum-resistant Recurrent Ovarian Cancer (PROC)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Platinum-resistant Recurrent Ovarian Cancer (PROC) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Platinum-resistant Recurrent Ovarian Cancer (PROC) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
his is an open-label, single-center, single-arm, prospective Phase II trial evaluating the efficacy and safety of Mirvetuximab Soravtansine (MIRV) combined with…
A Phase 1, single-arm, single-center, open-label, prospective, dose-escalation, and cohort expansion study to assess the safety, tolerability, pharmacokinetic (…